New COVID-19 Boosters Target Current Coronavirus Variants

Updated boosters could go to the “worried well” who have good insurance rather than to those at highest risk.

The ruling centered on PrEP as HIV prevention but could apply to cancer screenings and other services and drugs.

Insurers should allow co-pay assistance to count as out-of-pocket spending, claims HHS lawsuit by HIV, hepatitis and diabetes advocates.

Higher levels of viral antigens in the blood correlated with more severe disease.

After mishandling COVID-19 and monkeypox, the Centers for Disease Control and Prevention aims to change—with help from Mary Wakefield.

A federal lawsuit heard last month could upend or even eliminate the preventive care requirement in the law, known as Obamacare or the ACA.

Whether omicron coronavirus variants cause long COVID symptoms as often—and as severe—as previous variants is a matter of heated study.

Samples collected from sewage water suggest viral activity is higher than the number of reported cases suggests.

An experimental vaccine produced an immune response to a range of different coronaviruses in mice and monkeys, including SARS-CoV-2.